First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors Article

Jacob, Joseph M, Woldu, Solomon L, Linehan, Jennifer et al. (2024). First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors . UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 42(1), 10.1016/j.urolonc.2023.07.004

cited authors

  • Jacob, Joseph M; Woldu, Solomon L; Linehan, Jennifer; Labbate, Craig; Rose, Kyle M; Sexton, Wade J; Tachibana, Isamu; Kaimakliotis, Hristos; Nieder, Alan; Bjurlin, Marc A; Humphreys, Mitchell; Ghodoussipour, Saum B; Quek, Marcus L; Johnson, Brett; O'Donnell, Michael; Eisner, Brian H; Feldman, Adam S; Murray, Katie S; Matin, Surena F; Lotan, Yair; Dickstein, Rian J

sustainable development goals

authors

publication date

  • January 1, 2024

published in

keywords

  • Chemoablation
  • GRADE
  • Jelmyto
  • Life Sciences & Biomedicine
  • MANAGEMENT
  • Oncology
  • Science & Technology
  • TRACT UROTHELIAL CARCINOMA
  • UGN-101
  • UTUC
  • Upper tract urothelial cancer
  • Ureter
  • Ureteral
  • Ureteral cancer
  • Urology & Nephrology

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

volume

  • 42

issue

  • 1